Thursday, November 6, 2014

Results from first global survey of neuroendocrine tumor (NET) patients reveal profound impact of this rare cancer on quality of life

Results from first global survey of neuroendocrine tumor (NET) patients reveal profound impact of this rare cancer on quality of life
Neurology News & Neuroscience News from Medical News Today

Novartis and the International Neuroendocrine Cancer Alliance (INCA) announced the quality-of-life results from the first global survey of patients with neuroendocrine tumors (NETs), a rare type of...

Original Article: http://www.medicalnewstoday.com/releases/284970.php
Postado por

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)